Geode Capital Management’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.47M Buy
1,116,847
+11,929
+1% +$37.1K ﹤0.01% 2912
2025
Q1
$3.74M Buy
1,104,918
+20,680
+2% +$69.9K ﹤0.01% 2800
2024
Q4
$6.15M Buy
1,084,238
+4,729
+0.4% +$26.8K ﹤0.01% 2640
2024
Q3
$6.32M Buy
1,079,509
+6,740
+0.6% +$39.4K ﹤0.01% 2638
2024
Q2
$8.49M Buy
1,072,769
+100,405
+10% +$794K ﹤0.01% 2421
2024
Q1
$9.05M Buy
972,364
+293,486
+43% +$2.73M ﹤0.01% 2382
2023
Q4
$5.73M Buy
678,878
+31,933
+5% +$270K ﹤0.01% 2634
2023
Q3
$5.01M Buy
646,945
+56,690
+10% +$439K ﹤0.01% 2639
2023
Q2
$6.76M Buy
590,255
+317,000
+116% +$3.63M ﹤0.01% 2533
2023
Q1
$2.11M Buy
273,255
+517
+0.2% +$3.99K ﹤0.01% 3000
2022
Q4
$1.66M Buy
272,738
+1,716
+0.6% +$10.5K ﹤0.01% 3127
2022
Q3
$1.6M Buy
271,022
+300
+0.1% +$1.78K ﹤0.01% 3161
2022
Q2
$1.6M Buy
270,722
+7,025
+3% +$41.5K ﹤0.01% 3197
2022
Q1
$2.01M Sell
263,697
-88,267
-25% -$672K ﹤0.01% 3253
2021
Q4
$953K Buy
351,964
+73,318
+26% +$199K ﹤0.01% 3746
2021
Q3
$732K Buy
278,646
+520
+0.2% +$1.37K ﹤0.01% 3842
2021
Q2
$1.15M Sell
278,126
-186,692
-40% -$771K ﹤0.01% 3519
2021
Q1
$2.19M Buy
464,818
+73,162
+19% +$345K ﹤0.01% 3217
2020
Q4
$2.8M Sell
391,656
-4,987
-1% -$35.6K ﹤0.01% 2899
2020
Q3
$4.23M Sell
396,643
-8,361
-2% -$89.2K ﹤0.01% 2494
2020
Q2
$5.11M Buy
405,004
+8,688
+2% +$110K ﹤0.01% 2331
2020
Q1
$3.63M Buy
396,316
+12,641
+3% +$116K ﹤0.01% 2336
2019
Q4
$5.35M Buy
383,675
+3,227
+0.8% +$45K ﹤0.01% 2413
2019
Q3
$6.55M Buy
380,448
+11,219
+3% +$193K ﹤0.01% 2219
2019
Q2
$10.1M Buy
369,229
+52,426
+17% +$1.43M ﹤0.01% 1951
2019
Q1
$6.06M Buy
316,803
+29,539
+10% +$565K ﹤0.01% 2219
2018
Q4
$2.7M Buy
287,264
+53,888
+23% +$506K ﹤0.01% 2590
2018
Q3
$4.42M Buy
233,376
+152
+0.1% +$2.88K ﹤0.01% 2432
2018
Q2
$4.56M Buy
233,224
+45,642
+24% +$892K ﹤0.01% 2378
2018
Q1
$3.52M Buy
187,582
+14,909
+9% +$280K ﹤0.01% 2460
2017
Q4
$2.87M Buy
172,673
+31,248
+22% +$519K ﹤0.01% 2551
2017
Q3
$2.91M Buy
141,425
+73,265
+107% +$1.51M ﹤0.01% 2528
2017
Q2
$610K Buy
68,160
+5,675
+9% +$50.8K ﹤0.01% 3291
2017
Q1
$827K Buy
62,485
+4,516
+8% +$59.8K ﹤0.01% 3114
2016
Q4
$738K Buy
57,969
+2,584
+5% +$32.9K ﹤0.01% 3127
2016
Q3
$665K Buy
55,385
+1,953
+4% +$23.4K ﹤0.01% 3138
2016
Q2
$587K Buy
53,432
+960
+2% +$10.5K ﹤0.01% 3154
2016
Q1
$458 Buy
52,472
+8,488
+19% +$74 ﹤0.01% 3279
2015
Q4
$963K Buy
+43,984
New +$963K ﹤0.01% 2928